Egalet Corp (EGLTQ)

Currency in USD
0.01
0.00(0.00%)
Closed·
Showing Egalet historical data. For real-time data please try another search
Day's Range
0.010.01
52 wk Range
0.000.01
Key Statistics
Prev. Close
0.01
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0-0
Volume
-
Average Volume (3m)
1.66M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Egalet Corp Company Profile

Zyla Life Sciences, a commercial-stage life sciences company, focuses on the development and marketing of various treatments for patients and healthcare providers. The company has a portfolio of various treatments for various types of pain and inflammation. Its commercial products include SPRIX nasal spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; ZORVOLEX, a novel formulation of diclofenac; VIVLODEX, a SoluMatrix formulation of meloxicam approved for osteoarthritis pain; INDOCIN suppositories; INDOCIN oral suspension products; and OXAYDO, an immediate-release oxycodone product for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate. The company was formerly known as Egalet Corporation. Zyla Life Sciences was founded in 2010 and is headquartered in Wayne, Pennsylvania. Zyla Life Sciences operates as a subsidiary of Assertio Holdings, Inc.

Employees
127

Earnings

Latest Release
May 14, 2020
EPS / Forecast
-1.90 / --
Revenue / Forecast
19.07M / --
EPS Revisions
Last 90 days

EGLTQ Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.